Red Flags Detected
- Going Concern (unchanged) — Auditor reaffirms substantial doubt about ability to continue as going concern; cash insufficient for next 12 months despite $5.3M on hand.
- Material Weakness (worsened) — Control deficiencies persist unresolved for second year; company still lacks resources to remediate accounting staff shortages and IT control gaps.
- Auditor Change (new) — WWC replaced WithumSmith+Brown as auditor effective 2025; WithumSmith+Brown served from 2024 through October 2025.
VSee doubles headcount, converts $8M debt to equity, but losses persist amid going concern
Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Aug 28, 2025 · ~2 min read
Key Changes
-
high
Physician headcount surged 4x to 93 board-certified doctors (from 24), driving total FTE count up 36% to 209. Revenue grew 40% to $14.6M, but cost of revenues jumped 124%, outpacing sales growth and pressuring margins.
Business & MD&A: Revenue and Headcount verify on EDGAR → -
high
Company converted $8M+ in debt (Quantum, Exchange, September 2024 notes) into 8.3M shares and raised $5.5M via Armistice private placement at $0.61/share. Common shares outstanding doubled to 33.2M, massive dilution for existing holders.
Notes: Debt Conversions and Equity Raises verify on EDGAR → -
high
Net loss narrowed 74% to $14.7M from $57.7M, but improvement is non-recurring—driven by absence of prior-year $56.7M goodwill impairment. Underlying loss worsened $13.7M due to $7.9M adverse fair value swings on debt instruments and higher interest expense.
MD&A: Net Loss and Other Income verify on EDGAR →
2 more material changes plus the full narrative summary — create a free account to see the rest. Takes 30 seconds.
Partner
Trade VSEEW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 8, 2026 6:27 PM